Business Standard

US business, GST drag Torrent Pharma Q1 net down by 35% at Rs 188 cr

Revenue dipped by 11.4% to Rs 1,374 cr

Representative image of pharmaceuticals.
Premium

Pharma

BS Reporter Ahmedabad
Ahmedabad-based pharmaceuticals major, Torrent Pharmaceuticals Limited has posted a 35 per cent year-on-year (YoY) dip in net profits at Rs 188 crore for the quarter ended June 30 as its revenues too dipped by 11.4 per cent.

For the first quarter of the current fiscal, Torrent Pharmaceuticals posted revenues of Rs 1,374 crore as against Rs 1,551 crores during the same period last year. 
 
EBIDTA for Q1FY18 was at Rs 400 crore as against Rs 462 crore during the same period last year. Profit after tax (PAT)was Rs 292 crore during the same period last year.

The company said that the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in